Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. [electronic resource]
Producer: 20081022Description: 1380-8 p. digitalISSN:- 1460-2105
- Aged
- Analysis of Variance
- Anastrozole
- Antineoplastic Agents, Hormonal -- therapeutic use
- Aromatase Inhibitors -- therapeutic use
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- chemistry
- Chemotherapy, Adjuvant
- Clinical Trials as Topic
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Ki-67 Antigen -- analysis
- Letrozole
- Lymphatic Metastasis
- Middle Aged
- Neoadjuvant Therapy -- methods
- Neoplasm Staging
- Nitriles -- therapeutic use
- Postmenopause
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Receptors, Estrogen -- analysis
- Reproducibility of Results
- Risk Assessment
- Risk Factors
- Tamoxifen -- therapeutic use
- Treatment Outcome
- Triazoles -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.